Sayson, Gonzaga S.
HRN: 00-47-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
CEFUROXIME 1.5GM (VIAL)
11/22/2022
11/29/2022
IVTT
1.5g
Q8
Pulmonary Infection/ Infiltrates
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes